404 related articles for article (PubMed ID: 9463670)
1. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.
Weinig M; Hakim JG; Gudza I; Tobaiwa O
Trans R Soc Trop Med Hyg; 1997; 91(5):570-2. PubMed ID: 9463670
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.
Park BC; Han BH; Ahn SY; Lee SW; Lee DH; Lee YN; Seo JH; Kim KW
J Viral Hepat; 1995; 2(4):195-202. PubMed ID: 7489347
[TBL] [Abstract][Full Text] [Related]
3. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection.
Lee CM; Lu SN; Changchien CS; Yeh CT; Hsu TT; Tang JH; Wang JH; Lin DY; Chen CL; Chen WJ
Cancer; 1999 Oct; 86(7):1143-50. PubMed ID: 10506697
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
5. [Low prevalence of ant-hepatitis c virus antibodies in hepatocellular carcinoma in Senegal].
Ka MM; Herve P; Leguenno B; Ndiaye MF; Diop TM; Diop B; Dangou JM; Bao O; Brechot C
Ann Gastroenterol Hepatol (Paris); 1996; 31(6):329-32. PubMed ID: 8920074
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America.
Hwang SJ; Tong MJ; Lai PP; Ko ES; Co RL; Chien D; Kuo G
J Gastroenterol Hepatol; 1996 Oct; 11(10):949-54. PubMed ID: 8912133
[TBL] [Abstract][Full Text] [Related]
7. Detection of serum HBV DNA and anti-HCV antibody in HBsAg seronegative patients with hepatocellular carcinoma in Japan.
Tokeshi S; Sata M; Tanikawa K
Kansenshogaku Zasshi; 1996 Feb; 70(2):103-7. PubMed ID: 8851381
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and prognostic differences between patients with hepatitis B- and C-related resectable hepatocellular carcinoma.
Chen TH; Tseng LM; Chau GY; Lui WY; Tsay SH; King KL; Loong CC; Hsia CY; Wu CW
J Formos Med Assoc; 2001 Jul; 100(7):443-8. PubMed ID: 11579608
[TBL] [Abstract][Full Text] [Related]
9. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma.
Lee SD; Lee FY; Wu JC; Hwang SJ; Wang SS; Lo KJ
Cancer; 1992 Jan; 69(2):342-5. PubMed ID: 1309428
[TBL] [Abstract][Full Text] [Related]
11. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
[TBL] [Abstract][Full Text] [Related]
12. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.
Tsai JF; Jeng JE; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
Br J Cancer; 1996 Jun; 73(12):1498-502. PubMed ID: 8664119
[TBL] [Abstract][Full Text] [Related]
13. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
14. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
[TBL] [Abstract][Full Text] [Related]
15. A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, southern China.
Okuno H; Xie ZC; Lu BY; Qin X; Takasu M; Kano H; Shiozaki Y; Inoue K
Cancer; 1994 Jan; 73(1):58-62. PubMed ID: 7506119
[TBL] [Abstract][Full Text] [Related]
16. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
17. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
18. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients.
Hassan MM; Zaghloul AS; El-Serag HB; Soliman O; Patt YZ; Chappell CL; Beasley RP; Hwang LY
J Clin Gastroenterol; 2001 Aug; 33(2):123-6. PubMed ID: 11468438
[TBL] [Abstract][Full Text] [Related]
19. The interrelationship between HBV-markers and HIV antibodies in patients with hepatocellular carcinoma.
Tswana SA; Moyo SR
J Med Virol; 1992 Jul; 37(3):161-4. PubMed ID: 1279108
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of HIV and hepatitis B virus (HBV) in selected African and Asian populations.
Mertens T; Tondorf G; Siebolds M; Kruppenbacher JP; Shrestha SM; Mauff G; Gürtler L; Eggers HJ
Infection; 1989; 17(1):4-7. PubMed ID: 2921088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
